Study of T-PRED(TM) Compared to Pred Forte(R)

Overview

Study of T-PRED(TM) compared to Pred Forte(R)

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Basic Science
    • Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
  • Study Primary Completion Date: August 2008

Interventions

  • Drug: T-PRED
    • T-PRED sterile ophthalmic solution
  • Drug: Pred Forte
    • Pred Forte sterile ophthalmic solution

Arms, Groups and Cohorts

  • Active Comparator: T-Pred
    • Tobramycin prednisolone acetate combination
  • Active Comparator: Pred Forte
    • Prednisolone acetate

Clinical Trial Outcome Measures

Primary Measures

  • Mean Aqueous Humor Prednisolone Acetate Concentration
    • Time Frame: 4 hours

Participating in This Clinical Trial

Inclusion Criteria

  • 18 years of age Exclusion Criteria:

  • No active or adverse disease

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Bausch & Lomb Incorporated
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Tim McNamara, PharmD, Study Director, ISTA Pharmaceuticals, Inc.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.